Atorvastatin ADME

Summary
Organism
Homo sapiens (human)
Reactome
R-HSA-9754706
PubChem
R-HSA-9754706
Description
  • Atorvastatin (ATV, brand name Lipitor), is a lipid-lowering drug of the statin class of medications. It inhibits the endogenous production of cholesterol in the liver, thereby lowering abnormally high cholesterol and lipid levels, and ultimately reducing the risk of cardiovascular disease. Statins inhibit the enzyme hydroxymethylglutaryl-coenzyme A reductase (HMGCR) , which catalyzes the critical step in cholesterol biosynthesis of HMG-CoA conversion to mevalonic acid. Statins are the most commonly prescribed medication for treating abnormal lipid levels (Malhotra & Goa 2001). ATV and its hydroxy-metabolites collectively inhibit HMGCR to reduce circulating low-density lipoprotein cholesterol.

    ATV is transported in the blood almost exclusively bound to plasma proteins (>98%) (Lennernas 2003), and is subject to pre‑systemic clearance at the gastrointestinal tract and to first‑pass hepatic clearance, which explains its low systemic bioavailability (~12%) (Garcia et al. 2003). Organic anion transporters OATP1B1, OATP1B3 and OATP2B1, encoded by SLCO1B1, SLCO1B3, and SLCO2B1, respectively are expressed on the sinusoidal membrane of hepatocytes and can facilitate the liver uptake of drugs such as ATV (Kalliokoski & Niemi 2009).

    In hepatocytes (and to a lesser extent, the GI tract), ATV can be hydroxylated by cytochrome P450 3A4 (CYP3A4) to hydroxy-metabolites, or undergo lactonization via an unstable acyl glucuronide intermediate to ATV lactone (ATVL) mediated by UGT1A3 and 1A1. ATVL may also be hydroxylated by CYP3A4 to hydroxylactone-metabolites. The lactone metabolites are inactive against HMGCR, but can be hydrolyzed via paraoxonases (PONs) to their corresponding hydroxy acids, which are active against HMGCR. Elimination of ATV and its metabolites is principally biliary with apparently no significant enterohepatic recirculation. Half-life (t1/2) is approximately 14 h for atorvastatin and 20–30 h for its metabolites (Schachter 2005).
Click on a node on the pathway to see its details. Glycoproteins are marked with a glycoprotein icon in their name.
Displaying all 7 entries
UniProt ID Protein Name Gene Symbol Pathway Viewer
P08183 ATP-dependent translocase ABCB1
  • ABCB1
  • MDR1
  • PGY1
view
P27169 Serum paraoxonase/arylesterase 1
  • PON
  • PON1
view
P35503 UDP-glucuronosyltransferase 1A3
  • GNT1
  • UGT1
  • UGT1A3
view
Q15166 Serum paraoxonase/lactonase 3
  • PON3
view
Q92887 ATP-binding cassette sub-family C member 2
  • ABCC2
  • CMOAT
  • CMOAT1
  • CMRP
  • MRP2
view
Q9NPD5 Solute carrier organic anion transporter family member 1B3
  • LST2
  • OATP1B3
  • OATP8
  • SLC21A8
  • SLCO1B3
view
Q9Y6L6 Solute carrier organic anion transporter family member 1B1
  • LST1
  • OATP1B1
  • OATP2
  • OATPC
  • SLC21A6
  • SLCO1B1
view

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: [email protected]

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.5.0

Last updated: April 6, 2026